Search results
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings - ...
Benzinga· 9 hours agoPfizer's Q1 earnings report expects EPS of 49 cents and $13.09 billion in revenues. Stock has...
Pfizer’s Earnings Are Due. Questions About the Company’s Outlook Linger.
Barrons.com· 4 hours agoMorgan analyst Chris Schott wrote that he doesn’t expect Pfizer to raise its 2024 guidance until the...
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
Motley Fool via Yahoo Finance· 15 hours agoI owned shares of Pfizer (NYSE: PFE) when the COVID-19 pandemic started. Watching the stock soar...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Why Pfizer (PFE) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 1 day agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
5 Top Stocks to Buy in May
Motley Fool via Yahoo Finance· 13 hours agoHowever, I think there's a compelling contrarian case for this beaten-down big pharma stock. Pfizer's sinking revenue, earnings, and share price ...
These 3 High-Yield Stocks Have Been Growing Their Dividends Non-Stop, And Analysts Expect Their...
Benzinga via Yahoo Finance· 1 day agoIncome-seeking investors are always on the lookout for reliable high-yield stocks with a history of...
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Zacks via Yahoo Finance· 9 hours agoPfizer has an encouraging earnings track record. It beat earnings estimates in each of the last four...
Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure
Investor's Business Daily· 4 days agoTherapeutics' gene therapy, Lenmeldy, in terms of price. Lenmeldy won its U.S. approval last month...
PFE Shares Experience Decline in Value – Knox Daily
Knox Daily· 6 days agoAnalyzing PFE Stock Performance During the last five days, there has been a surge of approximately 3.34%. Over the course of the year, Pfizer Inc. shares ...